DOI do preprint publicado https://doi.org/10.36660/abc.20200273
The Effect of Coronavirus Disease 2019 on Cardiovascular Diseases
DOI:
https://doi.org/10.1590/SciELOPreprints.628Palavras-chave:
Coronavirus, COVID 19, Cardiovascular Diseases/complications, Comorbidity, Hypertension, Heart Failure, Myocarditis, Acute Respiratory Syndrome, Pandemic, Mortality, Hospitalization, Critical CareResumo
Coronavirus disease 2019 (COVID-19) is a global pandemic affecting the world, seen in more than 1,300,000 patients. COVID-19 acts through the angiotensin-converting enzyme 2 (ACE2) receptor. Cardiovascular comorbidities are more common with COVID-19, and nearly 10% of cases develop myocarditis (22% of critical patients). Further research is needed to continue or discontinue ACE inhibitors and angiotensin receptor blockers, which are essential in hypertension and heart failure in COVID-19. Intensive research is promising for the treatment and prevention of COVID-19.
Downloads
Enviado
Postado
Como Citar
Série
Copyright (c) 2020 Lutfu Askin, Okan Tanrıverdi, Husna Sengul Askin

Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.


